ArticleVaccine2025
Better, worse, or holding the course? Analysis of HPV vaccination patterns in the US, 2008-2020.
Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purposeThis analysis aims to understand temporal HPV vaccination coverage patterns by Health and Human Services Region (hereafter, Region) and state from 2008 to 2020.
methodsWe analyzed National Immunization Survey-Teen data (2008-2020), assessing 6 measures addressing initiation and up-to-date status by sex, as available over time. We compared, annually, Regional coverage to the national average and state-level coverage to the Regional average, identifying states and Regions as positive or negative deviants for each measure if coverage estimates diverged by at least 5 percentage points in either direction.
resultsRegions 1 and 9 were positive deviants and Regions 4 and 6 were negative deviants. Within deviant Regions, there were positive and negative deviant states identified, including positive deviant states within negative deviant regions (e.g. North Carolina in Region 4) and the inverse (e.g. Connecticut in Region 1).
conclusionsThrough this novel visualization of national, Regional, and state-level HPV vaccine uptake, we unmasked patterns to support future evaluations and interventions. Future work should focus on identification and assessment of factors leading to success and opportunities for improvement for HPV vaccine promotion efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.